<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04239404</url>
  </required_header>
  <id_info>
    <org_study_id>PMI-CAD-PCI</org_study_id>
    <nct_id>NCT04239404</nct_id>
  </id_info>
  <brief_title>Prognostic Impact of PMI in Stable CAD Undergoing PCI</brief_title>
  <official_title>The Prognostic Impact of Periprocedural Myocardial Injury in Stable Coronary Artery Disease Patients Undergoing Elective Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, observational, prospective study. This study aims to observe the
      effect of periprocedural myocardial injury on cardiovascular events in patients undergoing
      elective percutaneous coronary intervention, and to detect the levels of serum inflammatory
      factors before and after intervention to predict the occurrence of periprocedural myocardial
      injury and its association with cardiovascular events.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major cardiac events</measure>
    <time_frame>12 months after PCI</time_frame>
    <description>cardiac death, target vessel revascularization, target lesion revascularization, non-fatal myocardial infarction, heart failure, angina pectoris</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum level of inflammatory factors</measure>
    <time_frame>1 day after PCI</time_frame>
    <description>Serum level of inflammatory factors including TNFÎ±, IL-6 and so on.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Periprocedural Myocardial Injury</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <arm_group>
    <arm_group_label>PMI</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-PMI</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples of the participants before and after percutaneous coronary intervention therapy
      were selected.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        In-patients with stable coronary artery disease undergoing elective percutaneous coronary
        intervention in Zhongshan Hospital will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  underwent elective coronary stenting

          -  patients permit informed consents

        Exclusion Criteria:

          -  acute STEMI

          -  NYHA class III-IV heart failure

          -  moderate-to-severe valvular disease

          -  missing post-PCI troponin results

          -  active infection, respiratory failure

          -  liver dysfunction (liver enzyme &gt;3xURL or bilirubin &gt;2xURL),

          -  malignancy and systemic connective tissue disease

          -  unable to get a informed consents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhangwei Chen, MD</last_name>
    <phone>+86 21 64041990</phone>
    <email>chen.zhangwei@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Danbo Lu, PhD</last_name>
    <phone>+86 21 64041990</phone>
    <email>lu.danbo@zs-hospital.sh.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>180 Fenglin Road</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 20, 2020</study_first_submitted>
  <study_first_submitted_qc>January 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>January 20, 2020</last_update_submitted>
  <last_update_submitted_qc>January 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

